2025-02-15 - Analysis Report
## Intuitive Surgical Inc. (ISRG) Stock Analysis Report

**0. Key Figures Overview:**

ISRG has significantly outperformed the S&P 500 (VOO) over the analyzed period, exhibiting a cumulative return far exceeding that of the benchmark index.  Recent price movements indicate a relatively strong upward trend, supported by positive earnings and consistent profitability.  However, certain valuation metrics warrant further investigation.

**1. Performance Comparison and Alpha/Beta Analysis:**

Intuitive Surgical Inc. (ISRG) is a medical device company that develops and markets the da Vinci surgical system.

* **Cumulative Return:** ISRG: 331.64%, VOO: 121.84%
* **Return Difference:** ISRG outperformed VOO by 209.8 percentage points (94% of its historical range).  This indicates a substantial outperformance relative to the market.

The provided Alpha/Beta analysis shows high CAGR (Compound Annual Growth Rate) across most periods, suggesting strong historical growth.  However, Beta values fluctuate, indicating varying sensitivity to market movements. Noteworthy is the increasing Alpha in the last few years, pointing to a growing degree of outperformance relative to the market.  The substantial market capitalization consistently demonstrates the company's scale and significant presence in the market.


| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 77.0% | 7.3% | 49.0% | -0.0 | 43.4 |
| 2016-2018  | 89.0% | 8.9% | 71.0% | 0.0 | 56.9 |
| 2017-2019  | 93.0% | 9.8% | 63.0% | 0.5 | 70.3 |
| 2018-2020  | 71.0% | 9.8% | 43.0% | 0.2 | 97.3 |
| 2019-2021  | 113.0% | 9.8% | 42.0% | 0.2 | 128.2 |
| 2020-2022  | 21.0% | 20.6% | 12.0% | 0.2 | 94.6 |
| 2021-2023  | 19.0% | 20.6% | -4.0% | 1.0 | 120.3 |
| 2022-2024  | 128.0% | 20.4% | 95.0% | 1.0 | 186.2 |
| 2023-2025  | 226.0% | 9.9% | 163.0% | 0.8 | 212.4 |


**2. Recent Price Movement:**

* **Closing Price:** $595.55
* **5-Day Moving Average:** $592.78
* **20-Day Moving Average:** $587.84
* **60-Day Moving Average:** $556.35

The price is above all three moving averages, suggesting a short-term upward trend. The recent price increase of $0.70 (0.7034%) from the previous close indicates a slight positive momentum.

**3. Technical Indicators and Expected Return:**

* **RSI:** 65.87 (Approaching overbought territory, suggesting potential near-term correction)
* **PPO:** -0.11 (Slightly negative, indicating bearish momentum)
* **20-Day Relative Divergence Change:** +2.5 (Short-term upward momentum)
* **Expected Return (2+ years):** 19.7% (Significant outperformance of the S&P 500 expected)

The slight price increase reflects a positive market sentiment. The combination of RSI and PPO suggests some caution might be warranted, although the positive relative divergence indicates continuing upward momentum. The high expected return reinforces the long-term investment potential.

**4. Recent Earnings Analysis:**

The earnings data show consistent revenue growth and relatively stable EPS.  However, there's a duplicate entry for 2024-10-18 which needs clarification.  A more detailed analysis requires further information such as year-over-year comparisons and comparisons to analyst expectations.


| Date       | EPS  | Revenue      |
|------------|------|--------------|
| 2024-10-18 | 1.59 | $2.04B       |
| 2024-07-19 | 1.48 | $2.01B       |
| 2024-04-19 | 1.54 | $1.89B       |
| 2023-10-20 | 1.18 | $1.74B       |
| 2024-10-18 | 1.18 | $1.74B       |


**5. Financial Information:**

Both revenue and profitability are consistently high, indicating a robust and profitable business model.  Equity is steadily increasing, while ROE (Return on Equity) fluctuates but remains generally healthy, albeit showing a recent slight decline.  Further analysis is needed to understand the underlying drivers of these trends.


**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2024-12-31 | $2.41B | 68.04% |
| 2024-09-30 | $2.04B | 67.41% |
| 2024-06-30 | $2.01B | 68.30% |
| 2024-03-31 | $1.89B | 65.87% |
| 2023-12-31 | $1.93B | 66.24% |


**Capital and Profitability:**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2024-12-31 | $16.43B | 4.17% |
| 2024-09-30 | $15.58B | 3.63% |
| 2024-06-30 | $14.71B | 3.58% |
| 2024-03-31 | $13.96B | 3.90% |
| 2023-12-31 | $13.31B | 4.56% |


**6. Overall Conclusion:**

ISRG demonstrates a strong historical performance, significantly outperforming the S&P 500.  The company's financials show consistent revenue growth and high profit margins. While recent technical indicators suggest some potential for near-term correction, the long-term outlook remains positive, supported by a high expected return. However,  a more comprehensive analysis incorporating valuation metrics (e.g., P/E ratio, PEG ratio) and a thorough investigation of the duplicate earnings data point is crucial before making any investment decisions.  Further investigation into the drivers of fluctuating ROE and Beta would also enhance the understanding of the company's risk profile and potential future performance.
